Sangamo Therapeutics, Inc.
REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES
Last updated:
Abstract:
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
Status:
Application
Type:
Utility
Filling date:
9 Jan 2020
Issue date:
30 Apr 2020